126 related articles for article (PubMed ID: 15584979)
1. Low-dose prophylactic platelet transfusions: time for further study, but too early for routine clinical practice.
Strauss RG
Transfusion; 2004 Dec; 44(12):1680-2. PubMed ID: 15584979
[No Abstract] [Full Text] [Related]
2. Low-dose prophylactic platelet transfusions in recipients of an autologous peripheral blood progenitor cell transplant and patients with acute leukemia: a randomized controlled trial with a sequential Bayesian design.
Tinmouth A; Tannock IF; Crump M; Tomlinson G; Brandwein J; Minden M; Sutton D
Transfusion; 2004 Dec; 44(12):1711-9. PubMed ID: 15584985
[TBL] [Abstract][Full Text] [Related]
3. Reticulated platelet monitoring after autologous peripheral haematopoietic progenitor cell transplantation.
Martinelli G; Merlo P; Fantasia R; Gioia F; Crovetti G
Transfus Apher Sci; 2009 Jun; 40(3):175-81. PubMed ID: 19398373
[TBL] [Abstract][Full Text] [Related]
4. Acute bleeding complications in patients after hematopoietic stem cell transplantation with prophylactic platelet transfusion triggers of 10 x 10(9) and 20 x 10(9) per L.
Nevo S; Fuller AK; Hartley E; Borinsky ME; Vogelsang GB
Transfusion; 2007 May; 47(5):801-12. PubMed ID: 17465944
[TBL] [Abstract][Full Text] [Related]
5. [Thrombocyte substitution in hematologic patients].
Wiesneth M
Beitr Infusionsther; 1993; 31():86-91. PubMed ID: 7693270
[TBL] [Abstract][Full Text] [Related]
6. A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation.
Wandt H; Schaefer-Eckart K; Frank M; Birkmann J; Wilhelm M
Bone Marrow Transplant; 2006 Feb; 37(4):387-92. PubMed ID: 16400342
[TBL] [Abstract][Full Text] [Related]
7. [Donor peripheral stem cells infusion for the treatment of failure of platelet recovery after allogeneic hematopoietic stem cell transplantation].
Chen Y; Xu LP; Liu DH; Chen YH; Han W; Shi HX; Zhang XH; Wang JZ; Chen H; Liu KY; Huang XJ; Lu DP
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(14):964-6. PubMed ID: 17650420
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML/MDS patients receiving allogeneic hematopoietic stem cell transplantation.
Gurkan E; Patah PA; Saliba RM; Ramos CA; Anderson BS; Champlin R; de Lima M; Lichtiger B
Bone Marrow Transplant; 2007 Sep; 40(5):461-4. PubMed ID: 17589530
[TBL] [Abstract][Full Text] [Related]
9. [Current status and problem of platelet transfusion for hematopoietic diseases: results from a questionnaire survey].
Kato H; Handa M; Takamoto S
Rinsho Ketsueki; 2006 Dec; 47(12):1514-20. PubMed ID: 17233469
[TBL] [Abstract][Full Text] [Related]
10. Failure to achieve a threshold dose of CD34+ CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation.
Sartor MM; Garvin F; Antonenas V; Bradstock KF; Gottlieb DJ
Bone Marrow Transplant; 2007 Nov; 40(9):851-7. PubMed ID: 17704793
[TBL] [Abstract][Full Text] [Related]
11. Immune and nonimmune causes of low recovery from leukodepleted platelet transfusions: a prospective study.
Levin MD; de Veld JC; van der Holt B; van 't Veer MB
Ann Hematol; 2003 Jun; 82(6):357-62. PubMed ID: 12719885
[TBL] [Abstract][Full Text] [Related]
12. Failure to achieve a threshold dose of CD34+CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation for multiple myeloma.
Wallington-Beddoe CT; Gottlieb DJ; Garvin F; Antonenas V; Sartor MM
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1386-93. PubMed ID: 19822297
[TBL] [Abstract][Full Text] [Related]
13. High incidence of secondary failure of platelet recovery after autologous and syngeneic peripheral blood stem cell transplantation in acute promyelocytic leukemia.
Narimatsu H; Emi N; Kohno A; Iwai M; Yanada M; Yokozawa T; Saito S; Shimada K; Kiyoi H; Naoe T; Yamamoto K; Morishita Y
Bone Marrow Transplant; 2007 Oct; 40(8):773-8. PubMed ID: 17700597
[TBL] [Abstract][Full Text] [Related]
14. [Clinical aspects of thrombocyte transfusion].
Kummer H
Beitr Infusionther Klin Ernahr; 1986; 15():156-64. PubMed ID: 3753407
[No Abstract] [Full Text] [Related]
15. They took a mulligan and mostly got it right … the issue of prophylactic platelet transfusion for patients receiving autologous stem cell transplantation.
Schiffer CA
Transfusion; 2014 Oct; 54(10):2372-4. PubMed ID: 25302734
[No Abstract] [Full Text] [Related]
16. Review of definitions and mechanisms of refractoriness to platelet transfusions.
Hester JP; Ventura GJ
Prog Clin Biol Res; 1990; 337():49-58. PubMed ID: 2191338
[No Abstract] [Full Text] [Related]
17. A prospective randomized trial of a prophylactic platelet transfusion trigger of 10 x 10(9) per L versus 30 x 10(9) per L in allogeneic hematopoietic progenitor cell transplant recipients.
Diedrich B; Remberger M; Shanwell A; Svahn BM; Ringdén O
Transfusion; 2005 Jul; 45(7):1064-72. PubMed ID: 15987349
[TBL] [Abstract][Full Text] [Related]
18. Platelet utilization and the transfusion trigger: a prospective analysis.
Greeno E; McCullough J; Weisdorf D
Transfusion; 2007 Feb; 47(2):201-5. PubMed ID: 17302764
[TBL] [Abstract][Full Text] [Related]
19. Platelet transfusion therapy.
Slichter SJ
Hematol Oncol Clin North Am; 2007 Aug; 21(4):697-729, vii. PubMed ID: 17666286
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic platelet transfusions in acute myeloid leukemia.
Atkins CD
N Engl J Med; 1998 May; 338(20):1468-9; author reply 1469-70. PubMed ID: 9583979
[No Abstract] [Full Text] [Related]
[Next] [New Search]
